NextCure, Inc. (NXTC) stock
NXTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.40+0.17 (+2.73%)
Close on Nov 13, 2026Market cap $29.30MP/E –Yield 0.00%
NextCure operating margin
Operating margin is operating income as a percentage of revenue.
NextCure's operating margin for the twelve months ending Dec 31, 2020 was -184.2%. For fiscal 2020 it was -184.2%, against -590.5% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -184.2% | +406.3 |
| FY2019 | Dec 31, 2019 | -590.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2020 | Mar 31, 2020 | 36.7% | +538.9 |
| Q4 FY2019 | Dec 31, 2019 | -599.0% | – |
| Q3 FY2019 | Sep 30, 2019 | -612.9% | – |
| Q2 FY2019 | Jun 30, 2019 | -638.7% | – |
| Q1 FY2019 | Mar 31, 2019 | -502.2% | – |
See a number that looks wrong?